$KHOB
KHEOBA CORP.

2025 Q1 Form 10-K Financial Statement

#000147793225000026 Filed on January 03, 2025

View on sec.gov

Income Statement

Concept 2025 Q1 2024 Q4 2024
Revenue $41.06K
YoY Change 156.59%
Cost Of Revenue $14.00K
YoY Change
Gross Profit $27.06K
YoY Change 69.09%
Gross Profit Margin 65.9%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.653K
YoY Change 1041.17%
% of Gross Profit 24.59%
Operating Expenses $61.35K
YoY Change 282.31%
Operating Profit -$34.30K
YoY Change 72868.09%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$34.30K
YoY Change 72868.09%
Net Earnings / Revenue -83.53%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 8.092M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2025 Q1 2024 Q4 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.097K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $18.05K
Receivables
Other Receivables
Total Short-Term Assets $19.15K
YoY Change -35.7%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $17.39K
YoY Change 496.3%
TOTAL ASSETS
Total Short-Term Assets $19.15K
Total Long-Term Assets $17.39K
Total Assets $36.54K
YoY Change 11.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.398K
YoY Change -44.9%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $32.41K
YoY Change 217.51%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $32.41K
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$43.71K
YoY Change 364.38%
Common Stock $8.092K
YoY Change 10.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.133K
YoY Change
Total Liabilities & Shareholders Equity $36.54K
YoY Change 11.76%

Cashflow Statement

Concept 2025 Q1 2024 Q4 2024
OPERATING ACTIVITIES
Net Income -$34.30K
YoY Change 72868.09%
Depreciation, Depletion And Amortization $6.653K
YoY Change 1041.17%
Cash From Operating Activities -$23.13K
YoY Change 107.89%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$21.13K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $15.94K
YoY Change -38.46%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $28.58K
YoY Change 10.35%
NET CHANGE
Cash From Operating Activities -$23.13K
Cash From Investing Activities -$21.13K
Cash From Financing Activities $28.58K
Net Change In Cash -$15.68K
YoY Change -206.15%
FREE CASH FLOW
Cash From Operating Activities -$23.13K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001909770
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2025Q1 dei Entity Public Float
EntityPublicFloat
0 usd
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7295000 shares
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-10-31
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
333-263020
CY2024 dei Entity Registrant Name
EntityRegistrantName
KHEOBA CORP.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1636812
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
Petonal el Cerezo 8
CY2024 dei Entity Address Address Line2
EntityAddressAddressLine2
2A Los Realejos
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
38410
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Tenerife
CY2024 dei Entity Address Country
EntityAddressCountry
ES
CY2024 dei City Area Code
CityAreaCode
702
CY2024 dei Local Phone Number
LocalPhoneNumber
920-3738
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2025Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8092000 shares
CY2024 dei Auditor Name
AuditorName
Fruci & Associates II, PLLC
CY2024 dei Auditor Firm
AuditorFirmId
5525
CY2024 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2024Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1097 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16778 usd
CY2024Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18050 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13000 usd
CY2024Q4 us-gaap Assets Current
AssetsCurrent
19147 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
29778 usd
CY2024Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
9750 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
0 usd
CY2024Q4 kheo Capitalized Computer Website Net
CapitalizedComputerWebsiteNet
7644 usd
CY2023Q4 kheo Capitalized Computer Website Net
CapitalizedComputerWebsiteNet
2917 usd
CY2024Q4 us-gaap Assets
Assets
36541 usd
CY2023Q4 us-gaap Assets
Assets
32695 usd
CY2024Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1398 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2537 usd
CY2024Q4 kheo Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
14000 usd
CY2023Q4 kheo Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
0 usd
CY2024Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3300 usd
CY2024Q4 us-gaap Loans Payable Current
LoansPayableCurrent
12945 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
0 usd
CY2024Q4 kheo Due To Related Party Current
DueToRelatedPartyCurrent
4065 usd
CY2023Q4 kheo Due To Related Party Current
DueToRelatedPartyCurrent
4370 usd
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
32408 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10207 usd
CY2024Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7295000 shares
CY2024Q4 us-gaap Common Stock Value
CommonStockValue
8092 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
7295 usd
CY2024Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39748 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24605 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43707 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9412 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
4133 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
22488 usd
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36541 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32695 usd
CY2024 us-gaap Revenues
Revenues
41055 usd
CY2023 us-gaap Revenues
Revenues
16000 usd
CY2024 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2024 us-gaap Gross Profit
GrossProfit
27055 usd
CY2023 us-gaap Gross Profit
GrossProfit
16000 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12864 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1583 usd
CY2024 us-gaap Professional Fees
ProfessionalFees
48486 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
14464 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
61350 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
16047 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-34295 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-47 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-34295 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-47 usd
CY2024 kheo Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.00
CY2023 kheo Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.00
CY2024 kheo Basic And Diliuted Weighted Average Number Of Shares Outstanding
BasicAndDiliutedWeightedAverageNumberOfSharesOutstanding
8067182 shares
CY2023 kheo Basic And Diliuted Weighted Average Number Of Shares Outstanding
BasicAndDiliutedWeightedAverageNumberOfSharesOutstanding
6088232 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3365 usd
CY2023 kheo Common Shares Issued For Cash Amount
CommonSharesIssuedForCashAmount
25900 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-47 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
22488 usd
CY2024 kheo Common Shares Issued For Cash Amount
CommonSharesIssuedForCashAmount
15940 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-34295 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
4133 usd
CY2024 us-gaap Profit Loss
ProfitLoss
34295 usd
CY2023 us-gaap Profit Loss
ProfitLoss
47 usd
CY2024 us-gaap Depreciation
Depreciation
6653 usd
CY2023 us-gaap Depreciation
Depreciation
583 usd
CY2024 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3300 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3300 usd
CY2024 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5050 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
13000 usd
CY2024 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
14000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2024 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-305 usd
CY2023 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0 usd
CY2024 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024Q4 us-gaap Retained Earnings Unappropriated
RetainedEarningsUnappropriated
-43707 usd
CY2024 us-gaap Revenues
Revenues
41055 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3300 usd
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7295000 shares
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-9412 usd
CY2024 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
0 usd
CY2024Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9178 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1977 usd
CY2024Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9178 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1977 usd
CY2024Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2024Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
43707 usd
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8092000 shares
CY2024 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1140 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1963 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23132 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11127 usd
CY2024 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
13000 usd
CY2023 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
0 usd
CY2024 kheo Payments For Website Development Costs
PaymentsForWebsiteDevelopmentCosts
8130 usd
CY2023 kheo Payments For Website Development Costs
PaymentsForWebsiteDevelopmentCosts
0 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21130 usd
CY2023 us-gaap Interest Paid
InterestPaid
0 usd
CY2024 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
12945 usd
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15940 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25900 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28580 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25900 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-15682 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
14773 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16778 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2005 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1097 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16778 usd
CY2024Q4 kheo Related Party Loan Liabilities Transaction Amount
RelatedPartyLoanLiabilitiesTransactionAmount
4065 usd
CY2024Q4 kheo Related Party Loan Liabilities Transaction Amount
RelatedPartyLoanLiabilitiesTransactionAmount
4065 usd
CY2023 us-gaap Revenues
Revenues
16000 usd
CY2024 us-gaap Revenues
Revenues
41055 usd
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
427000 shares
CY2023Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8540 usd
CY2023Q3 us-gaap Share Price
SharePrice
0.02
CY2023Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
868000 shares
CY2023Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17360 usd
CY2023Q4 us-gaap Share Price
SharePrice
0.02
CY2023Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
755000 shares
CY2023Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15100 usd
CY2023Q4 us-gaap Share Price
SharePrice
0.02
CY2023Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
42000 shares
CY2023Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
840 usd
CY2023Q4 us-gaap Share Price
SharePrice
0.02
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8092000 shares
CY2024 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
43707 usd
CY2023 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
9412 usd
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-43707 usd
CY2023 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
0 usd

Files In Submission

Name View Source Status
0001477932-25-000026-index-headers.html Edgar Link pending
0001477932-25-000026-index.html Edgar Link pending
0001477932-25-000026.txt Edgar Link pending
0001477932-25-000026-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kheo-20241031.xsd Edgar Link pending
kheo_10k.htm Edgar Link pending
kheo_10kimg2.jpg Edgar Link pending
kheo_10kimg3.jpg Edgar Link pending
kheo_10k_htm.xml Edgar Link completed
kheo_ex311.htm Edgar Link pending
kheo_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
kheo-20241031_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
kheo-20241031_cal.xml Edgar Link unprocessable
kheo-20241031_pre.xml Edgar Link unprocessable
kheo-20241031_lab.xml Edgar Link unprocessable